Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction

Table 5 Duration of recombinant human follicle-stimulating hormone (r-hFSH) stimulation and total and daily r-hFSH doses required - Per-protocol population (patients who received hCG injections)

	CLD group	LD group	Total	p
	(n = 84)	(n = 82)	(N = 166)	p
Duration of stimulation, days	13.4 +/− 6.04	13.0 +/− 5.81	13.2 +/− 5.91	0.66
Daily dose, IU	78.5 +/− 8.95	85.5 +/− 15.88	81.9 +/− 13.28	<0.001
Total dose, IU	1092.9 +/− 665.19	1183.1 +/− 762.52	1137.4 +/− 714.18	0.42

Data are mean +/− standard deviation.
p values show the difference between treatment groups using analysis of variance.
Values in bold are significant.
CLD = chronic low-dose; hCG = human chorionic gonadotrophin; LD = low-dose.

ISSN: 1477-7827